BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2026.
World J Gastroenterol. Feb 28, 2026; 32(8): 114268
Published online Feb 28, 2026. doi: 10.3748/wjg.v32.i8.114268
Figure 4
Figure 4 Progression-free survival curve. A: Progression-free survival curve based on the neutrophil-to-lymphocyte ratio; B: Progression-free survival curve based on somatostatin analog use. Hazards ratio values were derived from Kaplan-Meier calculations. HR: Hazards ratio; CI: Confidence interval; NLR: Neutrophil-to-lymphocyte ratio; SSA: Somatostatin analog.


Write to the Help Desk